Fosciclopirox disodium

Fosciclopirox disodium is a prodrug that selectively delivers the active agent Ciclopirox to the urinary tract, where it inhibits urothelial cancer growth by targeting the γ-secretase complex. Ciclopirox has demonstrated broad anticancer activity in preclinical models of solid and hematologic malignancies, supporting its investigation in both in vitro and in vivo oncology research.